6219 studies found for:
"Gastrointestinal Neoplasms"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors
|
||||
| 2 | Recruiting |
Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Gastro-intestinal Tumors
|
||||
| 3 | Completed |
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
|
||||
| 4 | Completed |
A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
|
||||
| 5 | Completed |
The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients
|
||||
| 6 | Recruiting |
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
|
||||
| 7 | Completed |
Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors
|
||||
| 8 | Approved for marketing |
A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer
|
||||
| 9 | Completed |
Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma
|
||||
| 10 | Recruiting |
Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation
|
||||
| 11 | Recruiting |
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer
|
||||
| 12 | Not yet recruiting |
Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
|
||||
| 13 | Completed |
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
|
||||
| 14 | Completed |
Endoscopic Stenting of Gastrointestinal Cancer
|
||||
| 15 | Completed |
Endoscopic Submucosal Dissection Registry
|
||||
| 16 | Recruiting |
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
|
||||
| 17 | Terminated |
Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies
|
||||
| 18 | Active, not recruiting |
Acupuncture for the Immune System in Radiation Cancer Patients
|
||||
| 19 | Completed |
A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas
|
||||
| 20 | Recruiting |
Permission to Collect Blood Over Time for Research
|
† Indicates status has not been verified in more than two years
